Company intelligence / Profile preview
Pioneer Pharmaceutical
Sulaymaniyah, Sulaymaniyah, Iraqpioneerpharma.org ↗
- Ownership
- Private
- Employees
- ~1350
- Development stage
- Other
01
Overview
Leading manufacturer of branded and generic medicines in Iraq; first in Iraq with GMP certification, strong private market leader since 2022; expansive manufacturing and regional distribution capacity.
- Therapeutic areas
- CardiovascularImmunologyOphthalmologyGastroenterologyNeurologyInfectious DiseasesPulmonologyMetabolic DisordersOther
- Modalities
- Small moleculeBiologicInjectableGeneral FormulationsCephalosporinsPenemsEye drops
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Local health authorities (Ministry of Health, Iraq)Kemadia (Iraqi medical procurement agency)International machinery suppliers for Blow-Fill-Seal (BFS) technology
Beyond the preview
Go deeper on Pioneer Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pioneer Pharmaceutical.